Jamie Theriault, APRN
Nurse Practitioner · Westbrook, MENPI 1063996809
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.5% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $567, 7.9 times the $72 reported in 2021. Among nurse practitioner clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$208
- Pharmacyclics LLC, An Abbvie Company$120
- Daiichi Sankyo Inc.$100
- Johnson & Johnson$79
- Amgen$65
- Takeda Pharmaceuticals U.S.A., Inc.$60
- plus $534 from 15 others
What the payments were for
- Food & beverage$1,05591%
- Education$1109%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $208 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $120 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Johnson & Johnson | 3 | $79 |
| Amgen | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| ADC Therapeutics America, Inc. | 3 | $56 |
| Pfizer | 3 | $56 |
| AstraZeneca | 2 | $54 |
| Merck | 3 | $50 |
| Sanofi | 2 | $44 |
| Novartis | 2 | $38 |
| GSK | 1 | $36 |
| Caris MPI, Inc. | 2 | $33 |
| EMD Serono, Inc. | 1 | $31 |
| Seagen Inc. | 1 | $26 |
| Epizyme, Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $17 |
How this compares
$1,165 in reported general payments places this provider in the 95th percentile of 740 nurse practitioner providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 32 | $920 |
| Dexamethasone | 32 | $722 |
| Ondansetron OdtOndansetron | 30 | $715 |
| Levothyroxine Sodium | 15 | $171 |
| Triamcinolone Acetonide | 13 | $141 |
| Prochlorperazine Maleate | 17 | $117 |
| Prednisone | 14 | $101 |
| Tramadol Hcl | 12 | $97 |
| Lorazepam | 21 | $86 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Westbrook
- Amanda MagnoliWestbrook$113K
- Jennifer CaldwellWestbrook$784
- Gisele CastonguayLewiston$26K
- Rachel Koransky-MatsonBangor$16K
- Denise ViekmanPortland$15K
- Kerri NeelYork$5K
- Mallory EvansYork$5K
- Karrie SweetPortland$5K
- Noelle CooperSouth Portland$4K
- Kimberlee SmithKittery$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.